2 Stocks That Have Doubled This Year and Are Still Worth Buying

However, TransMedics Group and FuboTV still have excellent spects that could lead to better-than-average returns over the long run

Image source: Getty Images

TransMedics Group TransMedics Group, a medical device specialist that developed an innovative method for storing organs for transplant, entered the year facing challenges

First, the company's guidance disappointed investors

Second, TransMedics was the subject of a short-seller report from Scorpion Capital, which made a series of serious allegations, including claims that TransMedics Group is engaged in organ trafficking

However, the company has performed well this year because of better-than-expected financial results

With results these, even the short-seller report that sank its stock price now looks a distant memory

The best part is that there is still considerable upside potential for TransMedics Group

The company's organ care system (OCS) nology aims to mimic the physiology of the human body, enabling the storage of organs for longer periods, which results in significantly higher usage rates compared to traditional cold storage methods

It's already hard enough to find available transplants

It's a shame if they go to waste due to poor storage

Thus, TransMedics Group is helping revolutionize the organ donation thanks to its OCS, and there is plenty of room for growth

The company estimates organ donations will grow at a decent rate through the next few years, at least

Capturing a larger of the market and imving utilization rates for existing organ donations -- even if there aren't more donors over time -- should lead to stronger financial results for TransMedics Group

That's why the stock remains a buy today, at least for investors willing to stay the course for a while, even after doubling in value already this year

FuboTV In January, ing specialist FuboTV announced it was merging with Disney's Hulu+ TV

The deal makes FuboTV far more attractive than it was before for several reasons

First, it helps diversify the company's offerings

FuboTV was known for its laser focus on sports ing, a niche of the market that can be somewhat seasonal

Second, the deal came with the cancellation of the Venu initiative

Disney, Fox, and Warner Bros

Discovery were planning to launch a competing sports-focused ing platform called Venu, which might have killed FuboTV altogether, considering the company's subscription growth rate had plummeted

Third, FuboTV got a nice infusion of cash as part of the deal

Last but not least, Disney is now FuboTV's majority holder

The backing of a longtime successful media giant with equally successful ventures in the ing niche will be of massive help to FuboTV

Yes, the stock has already skyrocketed this year, but considering the long-term opportunity in ing, there should still be plenty of upside for FuboTV

Even so, that's in the U. , one of the more penetrated

And even here, ing ly hasn't peaked

That points to a massive whitespace worldwide

FuboTV will have to deal with stiff competition, but the company's new standing after the merger with Hulu+ TV -- and the backing of Disney -- should work wonders over the long run

That's why the stock is still a buy

Sper Junior Bakiny has no position in any of the stocks mentioned

The Motley Fool has positions in and recommends TransMedics Group, Walt Disney, Warner Bros

Discovery, and fuboTV

The Motley Fool has a disclosure policy.